Healthcare & Medical Devices Global On demand · 24-48h

Global Veterinary Absorbable Sutures Market Strategic Research Report

Global Veterinary Absorbable Sutures Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary Absorbable Sutures Market
$1.26B2025
6.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Natural Polymers, Synthetic Polymers

By Application: Pets, Livestock, Aquatic Animals, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Katsan Medical Devices, MEDTRONIC, Boz Medical, Medico, VMG Vitrex Medical Group, Universal Sutures, Unisur Lifecare, Haidike, CROWNJUN, Orion Sutures, Lotus Surgicals, Corza Medical, Medico, VeterSut, YUYAN, XINHUA, Worldwide Medivest

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 134 pages
Market size 2025
$1.26B
Billion USD
Forecast CAGR
6.4%
2025-2032
Forecast 2032
$1.9B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Veterinary Absorbable Sutures market size is predicted to grow from US$ 1,264 million in 2025 to US$ 1,945 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

In 2025, global sales of veterinary absorbable sutures reached 680 million units, with an average selling price of US$1.9 per unit. Veterinary absorbable sutures are primarily used for soft tissue suturing in pet hospitals and large-scale livestock farming. They are defined as suture materials made from PGA, PGLA, PDO, or natural gut sutures, formed through weaving, coating, sterilization, and aseptic packaging, and capable of biodegrading within the animal's body. Upstream raw materials include polyglycolic acid granules, polydioxanone, polylactic acid copolymer, gut protein, silicone coating agents, and aluminum foil packaging materials. Downstream suppliers include pet hospitals, veterinary clinics, large animal surgical centers, and livestock and poultry farm disease treatment facilities. The supply relationship follows a "branded consumables + channel agency" model, with regional dispersion and reliance on local distribution systems. Future development prospects mainly lie in products with controllable absorption cycles, antibacterial coated sutures, low tissue reactivity materials, and visually labeled sutures.

Global total production capacity is estimated at approximately 850 million units per year in 2025, with an average industry gross profit margin of approximately 38-45%. The growth in demand is primarily driven by increased global pet healthcare spending (especially in China, Brazil, and Southeast Asia), accompanied by a rise in pet surgeries. Simultaneously, large-scale farms are becoming increasingly reliant on specialized veterinary services, leading to a wider adoption of absorbable sutures. Market opportunities lie in low-cost domestic substitution, specialized products (ophthalmology/tissue regeneration), deepening distribution networks, and OEM exports. This represents a stable sub-sector of medical consumables with moderate growth but continuously expanding demand.

The veterinary absorbable suture market is showing steady growth, driven by the rapid development of the global pet healthcare industry, the upgrading of professional management in livestock farming, and the rigid demand for high-quality surgical consumables. With the increasing number of pets and pet owners' rising demands for medical quality, the frequency of pet sterilization, soft tissue surgery, and routine surgical procedures continues to rise. At the same time, large-scale farms and livestock farms are increasingly reliant on animal surgery, disease management, and productive surgeries, providing a stable application scenario for absorbable sutures. Compared to non-absorbable sutures, veterinary absorbable sutures offer significant advantages in reducing postoperative follow-up visits, minimizing secondary procedures, and improving animal comfort, making them the preferred consumable for low-tension surgeries and routine pet surgeries.

The market competition landscape is characterized by fragmentation in the mid-range market and concentration of high-end brands. European, American, and Japanese companies dominate the high-end market with advanced materials, antibacterial coatings, and highly consistent processes, while Chinese and emerging market companies expand into the mid-range market with cost advantages, rapid supply, and localized services. Future development trends include antibacterial/low-reactive materials, customized sutures, digital traceability packaging, and integration with pet hospital information systems. Simultaneously, with the standardization and premiumization of the pet healthcare industry, companies can achieve long-term growth through technological upgrades, channel expansion, and product portfolio optimization. Overall, while veterinary absorbable sutures are not a high-growth category, demand is stable, the market size is continuously expanding, and they possess long-term investment and operational value.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Absorbable Sutures market?

What factors are driving Veterinary Absorbable Sutures market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Absorbable Sutures market opportunities vary by end market size?

How does Veterinary Absorbable Sutures break out by Type, by Application?

This report presents a comprehensive overview of the global Veterinary Absorbable Sutures market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Natural Polymers
  • Synthetic Polymers

Segment by Structure

  • Monofilament Thread
  • Braided Thread

Segment by Absorption Cycle

  • Absorption Cycle: 7–14 Days
  • Absorption Cycle: 20–30 Days
  • Others

Segment by Application

  • Pets
  • Livestock
  • Aquatic Animals
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Veterinary Absorbable Sutures market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pets, Livestock, Aquatic Animals evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Veterinary Absorbable Sutures Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.26B
2025
Forecast
$1.9B
2032
CAGR
6.4%
2025–2032
Gebieden
5
global
Key companies
Katsan Medical DevicesMEDTRONICBoz MedicalMedicoVMG Vitrex Medical GroupUniversal SuturesUnisur LifecareHaidike
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Natural PolymersSynthetic Polymers
By Application
PetsLivestockAquatic AnimalsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Natural Polymers
  • 3.1.3 Synthetic Polymers
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pets
  • 4.1.3 Livestock
  • 4.1.4 Aquatic Animals
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Katsan Medical Devices
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 MEDTRONIC
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Boz Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medico
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 VMG Vitrex Medical Group
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Universal Sutures
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Unisur Lifecare
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Haidike
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CROWNJUN
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Orion Sutures
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Lotus Surgicals
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Corza Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Medico
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 VeterSut
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 YUYAN
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 XINHUA
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Worldwide Medivest
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Veterinary Absorbable Sutures market?
The global Veterinary Absorbable Sutures market is estimated at US$ 1.26 billion in 2025 (base year) and is projected to reach US$ 1.95 billion by 2032.
What is the forecast CAGR for the Veterinary Absorbable Sutures market?
The market is expected to grow at a CAGR of 6.4% from 2026 to 2032, expanding from US$ 1.26 billion in 2025 to US$ 1.95 billion in 2032, roughly 1.5 times its base-year value.
What is Veterinary Absorbable Sutures?
In 2025, global sales of veterinary absorbable sutures reached 680 million units, with an average selling price of US$1.9 per unit. Veterinary absorbable sutures are primarily used for soft tissue suturing in pet hospitals and large-scale livestock farming. They are defined as suture materials made from PGA, PGLA, PDO, or natural gut sutures, formed through weaving, coating, sterilization, and aseptic packaging, and capable of biodegrading within the animal's body.
What are the main segments of the Veterinary Absorbable Sutures market by type?
By type, the market is segmented into Natural Polymers and Synthetic Polymers.
Which applications drive demand in the Veterinary Absorbable Sutures market?
Key applications covered include Pets, Livestock, Aquatic Animals and Others.
Who are the key players in the Veterinary Absorbable Sutures market?
Key players profiled include Katsan Medical Devices, MEDTRONIC, Boz Medical, Medico, VMG Vitrex Medical Group, Universal Sutures, Unisur Lifecare and Haidike, among 17 companies covered in total.
Which regions and countries are covered for Veterinary Absorbable Sutures?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Veterinary Absorbable Sutures market?
The growth in demand is primarily driven by increased global pet healthcare spending (especially in China, Brazil, and Southeast Asia), accompanied by a rise in pet surgeries.
Who should buy the Veterinary Absorbable Sutures market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pets, Livestock and Aquatic Animals, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Veterinary Absorbable Sutures market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.